The newborn outcomes (NBO) solution is a web-based system for referring newborn babies who screen positive for sickle cell disease (SCD) and thalassaemia.
The PHE infectious diseases in pregnancy screening (IDPS) programme national team is seeking feedback on a draft version of the updated laboratory handbook.
The newborn outcomes solution IT system is now live in all newborn blood spot laboratories.
Updated letter templates for antenatal screening laboratories to use when providing lower chance results to women following a combined or quadruple screening test.
An update on the outcome of the laboratory testing services procurement process and the target date for commencement of the offer of NIPT.
Pregnant trans men can face some unique challenges when accessing healthcare.
Important reminders about ensuring NHS Fetal Anomaly Screening Programme samples are taken, stored and transported correctly.
PHE's newborn blood spot programme manager has praised her 'inspirational' colleague Professor Jim Bonham for his well-deserved MBE.
This blog article gives providers guidance on sickle cell and thalassaemia screening for women who are pregnant via egg donation.
We are pleased to announce the publication of new guidance for laboratories that are providing human papillomavirus (HPV) testing and cervical cytology services for the NHS Cervical Screening Programme. Please note that an incorrect version of the new guidance for …